It's been a whirlwind week! Yesterday, I took a 24-hour business trip to Vancouver, Canada. I just got back to Los Angeles about an hour ago, and later today I will head out again -- this time to China for a two-week visit.
I'm thrilled to be returning to China. While I'm there, I'll be meeting up with my China Investment Tour group. And of course, I'll be doing research for my newsletters, China Strategy and Asia Edge by investigating the unprecedented wealth creation taking place in Asia today.
My schedule is jam-packed full of educational and exciting events. My first stop will be in Taipei, where I'll meet up with my wife, Yvonne, and our kids, who have already been in Taiwan for a couple of weeks.
Then we'll be off to Shanghai, where Yvonne and I will host a welcome dinner for our China Investment Tour group. While in Shanghai, I'll also meet with the Vice Chairman of Shanghai's Chamber of Commerce, my friend Gou Man-yuen. Mr. Gou is a successful real estate developer and multimillionaire investor with influential connections in both Beijing and Washington. He's a fan of China Strategy and has promised to share his insights on recent developments with China's newly minted multimillionaire entrepreneurs. We'll also talk about Gou's personal rags-to-riches story. I look forward to sharing our conversations with you.
After finishing up in Shanghai, I'll fly out to Shenzhen and have dinner with some of China's finest money managers. I plan to take advantage of our time together to talk about stocks, investing strategies and economic policies. The next day, I'll meet up with our tour group. We'll visit the top stock brokerage firm in Guangdong Province, China Merchants Securities, as well as the Shenzhen Stock Exchange. The brokerage firm will host a special dinner for our group and answer questions about China's recent stock market boom. I'll be sure to share the firm's analysis with you in upcoming Dispatches.
The next morning, our tour group and I will visit the headquarters of one of my biggest gainers--Mindray Medical (NYSE: MR). Since we have three medical doctors in our tour group, I expect the Mindray visit to be especially interesting. I plan to ask Mindray executives about the company's technological edge, its near-term growth plans, its foray into the U.S. market and developments in China's healthcare policies.
I'll be sure to fill you in on all the details of my trip and, if you're interested, you can find out more about me and my trip on my China Strategy web site.